Not new to awards, Shiladitya has won the Shakuntala Amir Chand Prize for excellence in Medical Research from the Indian Council of Medical Research (ICMR) and the Geeta Mital Gold Medal from AIIMS. He has also received the Amanda Stavely Prize in the Cambridge University 50K entrepreneurship competition.

It was at Trinity (he also met his wife Shivani here) that he started working in the field of angiogenesis. After joining MIT as a postdoctoral associate, he started working on a problem that had plagued this field -- how to deliver chemotherapy after the blood vessels to the tumor have been cut off. As the Technology Review magazine says, his biggest discovery, that of the 'nanocell', is a nanoscale drug delivery device to treat cancer.

Recently, he joined the Harvard Medical School, Brigham and Women's Hospital as an Assistant Professor of medicine and the Harvard-MIT Division of Health Sciences and Technology

Shiladitya says, "Getting the TR35 Innovator award was a privilege…However, I take pride in the fact that a significant per cent of the winners were Indians, which reflects the innovative and entrepreneurial spirit within us as a nation."